4:37 PM ET
8-K
M&A Deal
Standard Biotools M&A Deal with Treeline Biosciences, Inc.
Standard BioTools Inc. provided a status update regarding its pending acquisition of Treeline Biosciences, Inc., specifically addressing stockholder litigation and demand letters. To avoid potential business delays and moot disclosure claims, the company issued supplemental disclosures to its definitive proxy statement ahead of the special meeting of stockholders scheduled for November 19, 2026.
- Counterparty
- Treeline Biosciences, Inc.